Patrick Wen, MD

Video

ASCO 2023: Glioma Research Presented by Patrick Wen, MD

The first phase 3 clinical trial of a molecularly targeted therapy for low grade IDH-mutant glioma showed positive results and opens the door to new possibilities for patients.